Henan Lingrui Pharmaceutical Co Ltd Total Liabilities
Henan Lingrui Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Henan Lingrui Pharmaceutical Co Ltd (600285) has total liabilities worth CN¥2.28 Billion CNY (≈ $333.69 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Henan Lingrui Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
Total liabilities of Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025. This chart illustrates how Henan Lingrui Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Henan Lingrui Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Henan Lingrui Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Henan Lingrui Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Domain Holdings Australia Ltd
AU:DHG
|
Australia | AU$369.52 Million |
|
Centrus Energy Corp.
NYSE MKT:LEU
|
USA | $1.68 Billion |
|
King’s Town Bank
TW:2809
|
Taiwan | NT$310.19 Billion |
|
Simplo Technology Co Ltd
TWO:6121
|
Taiwan | NT$37.50 Billion |
|
AVI LTD (UNSP.ADR)/5
F:IZ60
|
Germany | €4.53 Billion |
|
NRW Holdings Ltd
AU:NWH
|
Australia | AU$1.41 Billion |
|
Shanghai Xinhua Media Co Ltd
SHG:600825
|
China | CN¥1.42 Billion |
|
Diebold Nixdorf, Incorporated
NYSE:DBD
|
USA | $2.76 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Henan Lingrui Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600285 total assets.
Liquidity & Leverage Metrics
Henan Lingrui Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Henan Lingrui Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Henan Lingrui Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Henan Lingrui Pharmaceutical Co Ltd (1997–2025)
The table below shows the annual total liabilities of Henan Lingrui Pharmaceutical Co Ltd from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.20 Billion ≈ $321.87 Million |
+13.58% |
| 2024-12-31 | CN¥1.94 Billion ≈ $283.38 Million |
-1.86% |
| 2023-12-31 | CN¥1.97 Billion ≈ $288.74 Million |
+10.49% |
| 2022-12-31 | CN¥1.79 Billion ≈ $261.34 Million |
+18.55% |
| 2021-12-31 | CN¥1.51 Billion ≈ $220.45 Million |
+32.66% |
| 2020-12-31 | CN¥1.14 Billion ≈ $166.17 Million |
+3.68% |
| 2019-12-31 | CN¥1.10 Billion ≈ $160.28 Million |
+7.86% |
| 2018-12-31 | CN¥1.02 Billion ≈ $148.60 Million |
-7.98% |
| 2017-12-31 | CN¥1.10 Billion ≈ $161.48 Million |
+26.94% |
| 2016-12-31 | CN¥869.35 Million ≈ $127.21 Million |
-11.70% |
| 2015-12-31 | CN¥984.58 Million ≈ $144.07 Million |
+7.76% |
| 2014-12-31 | CN¥913.70 Million ≈ $133.70 Million |
+37.76% |
| 2013-12-31 | CN¥663.24 Million ≈ $97.05 Million |
+11.03% |
| 2012-12-31 | CN¥597.36 Million ≈ $87.41 Million |
+14.00% |
| 2011-12-31 | CN¥524.02 Million ≈ $76.68 Million |
+7.11% |
| 2010-12-31 | CN¥489.25 Million ≈ $71.59 Million |
+29.25% |
| 2009-12-31 | CN¥378.52 Million ≈ $55.39 Million |
-9.56% |
| 2008-12-31 | CN¥418.55 Million ≈ $61.25 Million |
+15.21% |
| 2007-12-31 | CN¥363.31 Million ≈ $53.16 Million |
-7.33% |
| 2006-12-31 | CN¥392.03 Million ≈ $57.37 Million |
-0.10% |
| 2005-12-31 | CN¥392.44 Million ≈ $57.43 Million |
+9.21% |
| 2004-12-31 | CN¥359.36 Million ≈ $52.59 Million |
+24.07% |
| 2003-12-31 | CN¥289.65 Million ≈ $42.38 Million |
+3.08% |
| 2002-12-31 | CN¥281.00 Million ≈ $41.12 Million |
+77.19% |
| 2001-12-31 | CN¥158.59 Million ≈ $23.21 Million |
+49.15% |
| 2000-12-31 | CN¥106.33 Million ≈ $15.56 Million |
-5.85% |
| 1999-12-31 | CN¥112.94 Million ≈ $16.53 Million |
+49.04% |
| 1998-12-31 | CN¥75.78 Million ≈ $11.09 Million |
+36.02% |
| 1997-12-31 | CN¥55.71 Million ≈ $8.15 Million |
-- |
About Henan Lingrui Pharmaceutical Co Ltd
Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orth… Read more